Factor VIII - China Biologic ProductsAlternative Names: Human coagulation factor VIII - China Biologics; Human coagulation factor VIII - Shandong Taibang
Latest Information Update: 25 Aug 2013
At a glance
- Originator China Biologic Products; Shandong Taibang Biological Products
- Class Antihaemorrhagics; Blood coagulation factors; Recombinant proteins
- Mechanism of Action Blood coagulation factor replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Haemophilia A
- Discontinued Haemorrhage
Most Recent Events
- 06 Aug 2013 Launched for Haemophilia A in China (IV) before August 2013